Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target is a research paper published in Molecular Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: F31‐CA254301
National Institutes of Health
Grant: K08‐7K08CA194162‐02
National Institutes of Health
Grant: R35 CA220500
National Institutes of Health
Grant: U54‐CA231630
National Institutes of Health
Grant: UL1TR002378
NCI NIH HHS
Grant: K08 CA194162
NCI NIH HHS
Grant: U54 CA231630
NCI NIH HHS
Grant: F31 CA254301
National Institutes of Health
Grant: 1F31CA254301-01
Role of MST/Hippo kinase inactivation in driving fusion-positive rhabdomyosarcoma
National Institutes of Health
Grant: 1R35CA220500-01
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
National Institutes of Health
Grant: 5UL1TR002378-09
Georgia Clinical & Translational Science Alliance (Georgia CTSA)
National Institutes of Health
Grant: 1K08CA194162-01A1
The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in Neuroblastoma
National Institutes of Health
Grant: 3U54CA231630-01A1S2
Defining and targeting the molecular vulnerabilities of the PAX3-FOXO1 protein in rhabdomyosarcoma
CURE Childhood Cancer
Sarcoma Foundation of America
FWCI
1.09
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals